Opus Genetics, Inc. Other Current Assets
Opus Genetics, Inc. (IRD) had Other Current Assets of $86.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-11-12
- 2024-09-30: Other Assets, Current $86.00K.
- 2024-06-30: Other Assets, Current $87.00K.
- 2024-03-31: Other Assets, Current $89.00K.
- 2023-12-31: Other Assets, Current $102.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2024-09-30 | $86.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $87.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $89.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $102.00K 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $51.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $45.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $78.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $80.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $61.00K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $31.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $33.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $71.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $46.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $73.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $26.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $26.00K 10-K · filed 2022-03-24 | |
| 2019-12-31 | $5.00K 10-K · filed 2021-03-11 | $447.21K 10-K · filed 2020-02-21 |
| 2019-09-30 | $606.36K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $662.10K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $410.16K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $555.43K 10-K · filed 2020-02-21 | |
| 2018-09-30 | $634.22K 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $779.36K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $491.64K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $510.60K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $666.05K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $667.04K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $424.12K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $429.04K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $675.34K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $796.39K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $629.32K 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $720.65K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $800.54K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $826.90K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $542.36K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $361.18K 10-K · filed 2016-03-14 | |
| 2014-09-30 | $531.80K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $650.05K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $638.77K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $469.40K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $487.63K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $378.62K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $170.18K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $175.99K 10-K · filed 2014-03-21 | |
| 2012-09-30 | $192.36K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $274.82K 10-Q · filed 2012-08-08 | |
| 2011-12-31 | $169.85K 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |